In Vitro Activity of Rifampicin Combined With Daptomycin or Tigecycline on Staphylococcus Haemolyticus Biofilms

Current Microbiology - United States
doi 10.1007/s00284-015-0821-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Effects of Growth in the Presence of Subinhibitory Concentrations of Dicloxacillin on Staphylococcus Epidermidis and Staphylococcus Haemolyticus Biofilms

Applied and Environmental Microbiology
Applied MicrobiologyBiotechnologyEcologyFood Science
2005English

The in Vitro Activity of Daptomycin Against Staphylococcus Aureus and Enterococcus Species

Journal of Antimicrobial Chemotherapy
Infectious DiseasesMicrobiologyPharmacology
2003English

In Vitro Activity of Iclaprim Against Methicillin-Resistant Staphylococcus Aureus Nonsusceptible to Daptomycin, Linezolid, or Vancomycin: A Pilot Study

Canadian Journal of Infectious Diseases and Medical Microbiology
Infectious DiseasesMicrobiology
2017English

Fitness Cost of Daptomycin-Resistant Staphylococcus Aureus Obtained From in Vitro Daptomycin Selection Pressure

Frontiers in Microbiology
Microbiology
2017English

Evaluation of High-Dose Daptomycin Versus Vancomycin Alone or Combined With Clarithromycin or Rifampin Against Staphylococcus Aureus and S. Epidermidis in a Novel in Vitro PK/PD Model of Bacterial Biofilm

Infectious Diseases and Therapy
Infectious DiseasesMicrobiology
2014English

Biofilm Formation by Staphylococcus Haemolyticus

Journal of Clinical Microbiology
Microbiology
2009English

Tigecycline Potentiates Clarithromycin Activity Against Mycobacterium Avium in Vitro

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2016English

In Vitro and in Vivo Activities of Tigecycline (GAR-936), Daptomycin, and Comparative Antimicrobial Agents Against Glycopeptide-Intermediate Staphylococcus Aureus and Other Resistant Gram-Positive Pathogens

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2002English

Systematic Evaluation of Commercial Susceptibility Testing Methods for Determining the in Vitro Activity of Daptomycin Versus Staphylococcus Aureus and Enterococci

Journal of Clinical Microbiology
Microbiology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy